Results 111 to 120 of about 6,309 (194)

Rationalisierung und Wettbewerb im Arzneimittelmarkt [PDF]

, 2012
Rationalisierungsmaßnahmen sind bei steigenden Ausgaben in einem vor allem durch Umlagen finanzierten Gesundheitssystem wichtige Mittel zur Erreichung einer effizienten Produktion und Allokation der Ressourcen.
Herr, Annika
core  

Transthyretin Amyloid Cardiomyopathy - Early Diagnosis is the Key for Better Outcomes

Journal of Indian College of Cardiology
Transthyretin amyloid cardiomyopathy (ATTR-CM) is rare and often diagnosed late. The incidence increases with advancing age, as ATTR tetramers become prone to misfolding and has been categorized as wild type and those due to gene mutations constitute ...
Immaneni Sathyamurthy, M. Indirani, Shelley Simon   +2 more
doaj   +1 more source

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview [PDF]

, 2017
The Concise Guide to PHARMACOLOGY 2017/18 is the third in this series of biennial publications. This version provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available ...
Abbracchio, MP, Al-Hosaini, K, Aldrich, R, Alexander, SPH, Arumugam, TV, Attali, B, Barnes, NM, Bathgate, R, Beart, PM, Becirovic, E, Bettler, B, Biel, M, Birdsall, NJ, Blaho, V, Boison, D, Bryant, C, Bräuner-osborne, H, Bröer, S, Buneman, OP, Burnstock, G, Bäck, M, Calo, G, Catterall, WA, Ceruti, S, Chan, SL, Chandy, KG, Chazot, P, Chiang, N, Christopoulos, A, Chun, JJ, Chung, JJ, Cidlowski, JA, Clapham, DE, Clapp, L, Connor, MA, Cox, HM, Davenport, AP, Davies, JA, Davies, P, Dawson, PA, Decaen, P, Dent, G, Doherty, P, Douglas, SD, Dubocovich, ML, Fabbro, D, Faccenda, E, Fong, TM, Fowler, CJ, Frantz, A, Fuller, P, Fumagalli, M, Futerman, AH, Gainetdinov, RR, Gershengorn, MA, Goldin, A, Goldstein, SAN, Goudet, C, Gregory, K, Grissmer, S, Gundlach, AL, Hagenbuch, B, Hamann, J, Hammond, JR, Hancox, JC, Hanson, J, Hanukoglu, I, Harding, SD, Hay, DL, Hobbs, AJ, Hollenberg, AN, Holliday, ND, Hoyer, D, Ijzerman, AP, Inui, KI, Irving, AJ, Ishii, S, Jacobson, KA, Jan, LY, Jarvis, MF, Jensen, R, Jockers, R, Kaczmarek, LK, Kanai, Y, Karnik, S, Kellenberger, S, Kelly, E, Kemp, S, Kennedy, C, Kerr, ID, Kihara, Y, Kukkonen, J, Larhammar, D, Marrion, NV, Pawson, AJ, Peters, JA, Sharman, JL, Southan, C, Spedding, M, Striessnig, J   +99 more
core  

The effect of long-term tafamidis treatment on quality of life in people with transthyretin amyloid cardiomyopathy (ATTR-CM): a plain language summary [PDF]

[Abstract] What is this summary about?: This summary explains some results of a study called ATTR-ACT and its ongoing long-term extension study that were published in the European Journal of Heart Failure.
Angeli, Franca Stedile, Crespo-Leiro, María Generosa, Davis, Margot K., Grogan, Martha, Gundapaneni, Balarama, Sultan, Marla B.   +5 more
core   +1 more source

Afectación cardiovascular en la amiloidosis. Revisón de la literatura y puesta al día [PDF]

, 2016
La amiloidosis es una enfermedad infiltrativa provocada por el depósito extracelular de material proteico fibrilar en los tejidos, existiendo formas localizadas y sistémicas. En esta última, destacan por su frecuencia la amiloidosis AL o primaria, que es
Rodrigo Manjón, Alejandro
core  

Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era

JACC: Advances
Background: Biomarker-based prognostic staging systems, including the National Amyloidosis Centre (NAC) and the Mayo staging systems, are widely-used but have only been validated for treatment-naive patients with cardiac transthyretin amyloidosis (ATTR ...
Maximilian Leo Müller, MD, Sebastian Spethmann, MD, Daniel Messroghli, MD, Anna Brand, MD, Isabel Mattig, MD, Katrin Hahn, MD, Ulf Landmesser, MD, Bettina Heidecker, MD   +7 more
doaj   +1 more source

Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial [PDF]

, 2015
Balarama Gundapaneni, Denis Keohane, Jeffrey Schwartz, Leslie Amass, Michelle Stewart   +4 more
core   +1 more source

Tafamidis for Cardiac Transthyretin Amyloidosis

Cardiovascular Prevention and Pharmacotherapy, 2021
Darae Kim, Jin-Oh Choi, Eun-Seok Jeon
openaire   +1 more source

Tafamidis bei TTR-FAP [PDF]

InFo Neurologie & Psychiatrie, 2012
openaire   +2 more sources

Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. [PDF]

Future Cardiol
Sarswat N, Ambardekar AV, Alexander KM, Cuddy SA, Stern L, Poulsen SH, Tschöpe C, Sekijima Y, Sheikh FH, Griffin JM, Judge DP, Gillmore J, Masri A.   +12 more
europepmc   +1 more source